Although pleiotropic enhancers are part of an emerging reality, it is important to note that they control the expression of only a subset of the tissues where the regulated gene is used, and are thus less pleiotropic than the coding regions they regulate. Pleiotropic enhancers instead provide us with a genetic mechanism to explain how some tissues are more connected than others, and why we find correlated evolution between seemingly unrelated traits. As we obtain a better sense for how commonly pleiotropy exists among enhancers, the next challenge will be to determine how well this predicts the pleiotropy of mutations to these elements. It may become apparent that there are many mutations that modify the activity of a pleiotropic enhancer in one tissue without affecting the other tissue [12] . Understanding these broader trends will be significant, as we begin to tackle the problem of which (if any) of the affected traits was subject to selection. For The crystal structure of SelO, a pseudokinase previously presumed to be inactive, reveals an ATP cofactor sitting in the active site in a flipped orientation compared with canonical kinases, leading to the discovery of an unexpected catalytic activity for this ancient enzyme.
Protein kinases -enzymes that attach phosphate groups to target proteins -are critical players in cell regulation and disease pathology, and are prized for being highly druggable targets. The kinase family is among the largest of protein families; however, about one in every ten protein kinases, identified as such on the basis of sequence homology, lacks one or more of the residues required for catalytic activity. These so-called pseudokinases have been a source of mystery and speculation since they were first discovered. A recent study by Sreelatha et al. [1] now reveals that the highly conserved pseudokinase SelO possesses an unexpected and 'inverted' catalytic activity for a protein kinase domain. The widespread presence of pseudokinase genes in the human genome was first discovered over 15 years ago [2, 3] . Many hypotheses arose over the years to explain these kinases. Perhaps they a have weak catalytic activity supported by compensatory mutations. Perhaps they allosterically regulate other proteins to which they bind, or act as scaffolds by binding to enzyme-substrate pairs and bringing them into close proximity with each other [4] . Perhaps they compete with active kinases for substrates. Many of these same ideas apply to the larger set of pseudoenzymes, which include proteases that cannot cleave proteins and phosphatases that cannot remove phosphates [4] . Over the years, evidence in favor of all of these alternatives has been found for some members of the pseudokinase group. Nevertheless, finding a new catalytic activity for a pseudokinase is certainly unexpected.
The SelO protein is a relatively new addition to the pseudokinase set. Using bioinformatic tools, Dudkiewicz et al. [5] first predicted in 2012 that it should adopt a protein kinase fold, but at the same time noted the absence of key catalytic residues required for canonical kinase activity. SelO is a member of the selenoproteins, so named because they contain one or more selenocysteines -a derivative of the amino acid cysteine in which selenium is found in place of the normal sulfur atom. Selenocysteine is the 21 st genetically encoded amino acid, specified by the combination of a UGA stop codon and a nearby RNA stem loop structure typically found in the 3'-untranslated region of the mRNA. Selenocysteine may have certain advantages over cysteine with regard to sensing the oxidation level of its environment and participating in certain oxidation-reduction reactions; indeed, many selenoproteins are involved in redox homeostasis [6] .
In the new study, Sreelatha et al. [1] crystallized the SelO homolog from the plant pathogen Pseudomonas syringae and solved its 3D structure. Although the kinase fold in the crystal structure confirmed the overall bioinformatic predictions, a big surprise was lurking elsewhere in the structure. Canonical protein kinases use ATP -an adenosine nucleoside attached to three phosphate groups -as a co-factor in the phosphorylation reaction. The third, or gamma, phosphate (the phosphate most distal to the adenosine moeity) is the one that gets attached to the protein substrate ( Figure 1 ). As several pseudokinases have been shown to still be able to bind ATP, the authors co-crystallized SelO with an ATP derivative commonly used in crystallization studies. The surprise came when the authors saw how this ATP was positioned in the structure. As in canonical kinases, the ATP was wedged into a cleft between the upper and lower lobes of the peanutshaped kinase domain. However, the positions of the third and first phosphates of ATP were flipped: in the SelO structure, the first phosphate was located where the third phosphate is usually found in canonical kinases, and conversely the first phosphate was situated where the third was supposed to be. Finally, the adenosine was not where it was supposed to be either; instead, a new pocket in the kinase domain had been created for it. The ATP in SelO was literally inserted backwards (Figure 1) .
The flipped orientation of the ATP in SelO provided a clue that soon led the authors to the unexpected catalytic activity of SelO. When canonical kinases attach the third phosphate of ATP to the substrate, they leave behind an ADP molecule (adenosine attached to two phosphates), which is then released. What SelO does instead is to attach an AMP molecule -adenosine attached to the first, or alpha, phosphateto the target protein, releasing a diphosphate (Figure 1 ). This process is known as AMPylation or adenylation, and is best known as a mechanism by which bacterial pathogens disarm and disable crucial regulatory proteins in their hosts. The relevant AMPylating enzymes in these pathogens do not resemble kinases, however [7] . By purifying a recombinant SelO protein and allowing it to auto-AMPylate, or to AMPylate a generic substrate, Sreelatha et al. [1] demonstrated that SelO is an AMPylating enzyme. Mutation of residues suggested by the structure to participate in catalysis abolished the AMPylation activity, confirming the accuracy of the structural predictions.
Conveniently, there are far fewer AMPylated proteins in a cell than phosphorylated proteins, and the AMP group is easier to grab ahold of. These advantages allowed Sreelatha et al. [1] to fish out two substrates of the Escherichia coli SelO homolog -GrxX and SucA. Both of these proteins have functions in oxidative phosphorylation and redox biology, consistent with the known roles of other selenoproteins in these processes. The authors also used mass spectrometry to identify the residues AMPylated by SelO in these two substrates and found that GrxX gets AMPylated in its active site, thereby likely inhibiting its activity.
Why does SelO do things backwards, AMPylating rather than phosphorylating? One likely answer is that AMP is bulkier than a phosphate group and thus is more likely to disrupt protein-protein binding or cause a dramatic conformational change. Another possibility is that AMP is harder to 
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Dispatches remove from proteins than standard phosphate groups, which are cleaved off by a battery of cellular phosphatases. Pathogens presumably use AMPylation for both these reasons: AMP is a better blocker that's harder to remove. An interesting question for future work is whether there are enzymes that reverse SelO-catalyzed AMPylations, or whether AMPylated substrates are ultimately cleared by degradation instead.
One hypothesis about pseudokinases that has definitely not stood up to scrutiny is that pseudokinases are junky evolutionary remnants. Rather, pseudokinases turned out to be highly conserved across the kingdoms and phyla of life, both with respect to the presence of residues that give them that attractive protein kinase fold and the absence of residues that give them that catalytic spark. Indeed, Sreelatha et al. [1] put this conservation to good use: although they crystallized SelO from a bacterial plant pathogen, they performed biochemical studies on SelO proteins from humans and from the workhorse bacterium E. coli, and they also carried out genetic analyses of SelO in yeast. This last set of experiments showed that SelO is targeted to yeast mitochondria, where it protects yeast cells from oxidative stress.
Human and other higher eukaryotic SelO proteins contain a single selenocysteine residue near their carboxyl terminus, distal to the kinase domain. What's it doing there? Sreelatha et al. [1] found biochemical evidence that the equivalent residue in E. coli SelO (which happens to be a regular old cysteine in this organism) forms an intramolecular disulfide bond with a cysteine in the activation loop. The activation loop is one of the key flexible regulatory elements in canonical kinases, and it typically undergoes regulated refolding following post-translational modification or protein binding [8] . Having its activation loop locked up in a disulfide bridge inhibits the AMPylation activity of E. coli SelO, illuminating how the oxidation state might regulate the activity of SelO enzymes.
There are several open questions raised by the new study. For example, how is the substrate specificity of SelO determined? Is SelO part of an ancient, conserved oxidative stress defense pathway? Finally, are there other pseudokinases that are AMPylating enzymes or, alternatively, that have some other clever catalytic activity that isn't canonical phosphorylation?
The canonical eukaryotic protein kinase domain is a remarkable structure [9, 10] . It executes the most widely used regulatory post-translational modification with efficiency and fidelity. It responds exquisitely to multiple types of regulatory input. It uses various parts of its surface to dock to substrates, bind to scaffolds and regulators, and dimerize [11, 12] . It can act as an allosteric regulator or a scaffold itself, whether in its canonical or pseudo flavor, because it has parts that can rotate, flip and even completely refold [8, 13] . And now we know that it can also evolve new catalytic activities that go beyond ATP hydrolysis and phosphorylation [1] .
